Zinc‐Organometallic Framework Vaccine Controlled‐Release Zn²⁺ Regulates Tumor Extracellular Matrix Degradation Potentiate Efficacy of Immunotherapy

Zinc‐Organometallic Framework Vaccine Controlled‐Release Zn²⁺ Regulates Tumor Extracellular Matrix Degradation Potentiate Efficacy of Immunotherapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Zinc‐Organometallic Framework Vaccine Controlled‐Release Zn²⁺ Regulates Tumor Extracellular Matrix Degradation Potentiate Efficacy of Immunotherapy have?

Zinc‐Organometallic Framework Vaccine Controlled‐Release Zn²⁺ Regulates Tumor Extracellular Matrix Degradation Potentiate Efficacy of Immunotherapy has 65 citations in the OpenAlex counts ScholarIQ stores.

When was Zinc‐Organometallic Framework Vaccine Controlled‐Release Zn²⁺ Regulates Tumor Extracellular Matrix Degradation Potentiate Efficacy of Immunotherapy published?

Zinc‐Organometallic Framework Vaccine Controlled‐Release Zn²⁺ Regulates Tumor Extracellular Matrix Degradation Potentiate Efficacy of Immunotherapy has 2023 year in the ScholarIQ index.

What is the open-access status of Zinc‐Organometallic Framework Vaccine Controlled‐Release Zn²⁺ Regulates Tumor Extracellular Matrix Degradation Potentiate Efficacy of Immunotherapy?

Zinc‐Organometallic Framework Vaccine Controlled‐Release Zn²⁺ Regulates Tumor Extracellular Matrix Degradation Potentiate Efficacy of Immunotherapy has gold oa status in the ScholarIQ index.

What is the DOI of Zinc‐Organometallic Framework Vaccine Controlled‐Release Zn²⁺ Regulates Tumor Extracellular Matrix Degradation Potentiate Efficacy of Immunotherapy?

The DOI for Zinc‐Organometallic Framework Vaccine Controlled‐Release Zn²⁺ Regulates Tumor Extracellular Matrix Degradation Potentiate Efficacy of Immunotherapy is on the source record.

What is the PMID of Zinc‐Organometallic Framework Vaccine Controlled‐Release Zn²⁺ Regulates Tumor Extracellular Matrix Degradation Potentiate Efficacy of Immunotherapy?

The PMID for Zinc‐Organometallic Framework Vaccine Controlled‐Release Zn²⁺ Regulates Tumor Extracellular Matrix Degradation Potentiate Efficacy of Immunotherapy is on the source record.

What is the OpenAlex record for Zinc‐Organometallic Framework Vaccine Controlled‐Release Zn²⁺ Regulates Tumor Extracellular Matrix Degradation Potentiate Efficacy of Immunotherapy?

The OpenAlex for Zinc‐Organometallic Framework Vaccine Controlled‐Release Zn²⁺ Regulates Tumor Extracellular Matrix Degradation Potentiate Efficacy of Immunotherapy is on the source record.